{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T15:13:32Z","timestamp":1791213212188,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100006293","name":"ASCO","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006293","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006034","name":"USC","doi-asserted-by":"publisher","award":["CA014089"],"award-info":[{"award-number":["CA014089"]}],"id":[{"id":"10.13039\/100006034","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Anton B. Burg Foundation"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","cancergeneticsjournal.org","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Genetics"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.cancergen.2015.12.007","type":"journal-article","created":{"date-parts":[[2015,12,22]],"date-time":"2015-12-22T05:35:57Z","timestamp":1450762557000},"page":"75-81","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["A novel BAP1 mutation is associated with melanocytic neoplasms and thyroid cancer"],"prefix":"10.1016","volume":"209","author":[{"given":"Kevin J.","family":"McDonnell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory T.","family":"Gallanis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6928-7359","authenticated-orcid":false,"given":"Kathleen A.","family":"Heller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilena","family":"Melas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory E.","family":"Idos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie O.","family":"Culver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sue-Ellen","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David H.","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen B.","family":"Gruber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cancergen.2015.12.007_bib0010","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12013-011-9184-6","article-title":"An emerging model for BAP1's role in regulating cell cycle progression","volume":"60","author":"Eletr","year":"2011","journal-title":"Cell Biochem Biophys"},{"key":"10.1016\/j.cancergen.2015.12.007_bib0015","doi-asserted-by":"crossref","first-page":"34179","DOI":"10.1074\/jbc.M109.046755","article-title":"The deubiquitinating enzyme BAP1 regulates cell growth via interaction with HCF-1","volume":"284","author":"Machida","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cancergen.2015.12.007_bib0020","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.biocel.2015.01.001","article-title":"BAP1 regulates cell cycle progression through E2F1 target genes and mediates transcriptional silencing via H2A monoubiquitination in uveal melanoma cells","volume":"60C","author":"Pan","year":"2015","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.cancergen.2015.12.007_bib0025","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1073\/pnas.1309085110","article-title":"Tumor suppressor and deubiquitinase BAP1 promotes DNA double-strand break repair","volume":"111","author":"Yu","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cancergen.2015.12.007_bib0030","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/embr.201338373","article-title":"Regulation of stem cell function by protein ubiquitylation","volume":"15","author":"Strikoudis","year":"2014","journal-title":"EMBO Rep"},{"key":"10.1016\/j.cancergen.2015.12.007_bib0035","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/1479-5876-10-179","article-title":"BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs","volume":"10","author":"Carbone","year":"2012","journal-title":"J Transl Med"},{"key":"10.1016\/j.cancergen.2015.12.007_bib0040","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1126\/science.1194472","article-title":"Frequent mutation of BAP1 in metastasizing uveal melanomas","volume":"330","author":"Harbour","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.cancergen.2015.12.007_bib0045","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1038\/ng.912","article-title":"Germline BAP1 mutations predispose to malignant mesothelioma","volume":"43","author":"Testa","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.cancergen.2015.12.007_bib0050","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1038\/ng.910","article-title":"Germline mutations in BAP1 predispose to melanocytic tumors","volume":"43","author":"Wiesner","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.cancergen.2015.12.007_bib0055","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1136\/jmedgenet-2011-100156","article-title":"Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancers","volume":"48","author":"Abdel-Rahman","year":"2011","journal-title":"J Med Genet"},{"key":"10.1016\/j.cancergen.2015.12.007_bib0060","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.ajhg.2013.04.012","article-title":"Germline BAP1 mutations predispose to renal cell carcinomas","volume":"92","author":"Popova","year":"2013","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.cancergen.2015.12.007_bib0065","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/cge.12472","article-title":"Germline BAP1 mutations predispose also to multiple basal cell carcinomas","volume":"88","author":"de la Fouchardiere","year":"2015","journal-title":"Clin Genet"},{"key":"10.1016\/j.cancergen.2015.12.007_bib0070","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/cge.12501","article-title":"A recurrent germline BAP1 mutation and extension of the BAP1 tumor predisposition spectrum to include basal cell carcinoma","volume":"88","author":"Wadt","year":"2015","journal-title":"Clin Genet"},{"key":"10.1016\/j.cancergen.2015.12.007_bib0075","doi-asserted-by":"crossref","first-page":"e35295","DOI":"10.1371\/journal.pone.0035295","article-title":"Germline BAP1 inactivation is preferentially associated with metastatic ocular melanoma and cutaneous-ocular melanoma families","volume":"7","author":"Njauw","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cancergen.2015.12.007_bib0080","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1093\/nar\/16.3.1215","article-title":"A simple salting out procedure for extracting DNA from human nucleated cells","volume":"16","author":"Miller","year":"1988","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.cancergen.2015.12.007_bib0085","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1053\/j.seminoncol.2007.09.006","article-title":"Genetics: what advice for patients who present with a family history of melanoma?","volume":"34","author":"Newton Bishop","year":"2007","journal-title":"Semin Oncol"},{"key":"10.1016\/j.cancergen.2015.12.007_bib0090","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/S0190-9622(85)70248-4","article-title":"Age distribution and histologic patterns of dysplastic nevi","volume":"13","author":"Sagebiel","year":"1985","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.cancergen.2015.12.007_bib0095","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1038\/jid.2008.18","article-title":"Epidemiologic support for melanoma heterogeneity using the surveillance, epidemiology, and end results program","volume":"128","author":"Lachiewicz","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.cancergen.2015.12.007_bib0100","doi-asserted-by":"crossref","first-page":"e337","DOI":"10.1200\/JCO.2011.41.2965","article-title":"Toward an improved definition of the tumor spectrum associated with BAP1 germline mutations","volume":"30","author":"Wiesner","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cancergen.2015.12.007_bib0105","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1158\/1541-7786.MCR-13-0111","article-title":"A novel germline mutation in BAP1 predisposes to familial clear-cell renal cell carcinoma","volume":"11","author":"Farley","year":"2013","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.cancergen.2015.12.007_bib0110","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/gcc.22129","article-title":"Expanding the clinical phenotype of hereditary BAP1 cancer predisposition syndrome, reporting three new cases","volume":"53","author":"Pilarski","year":"2014","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cancergen.2015.12.007_bib0115","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1038\/sj.onc.1201861","article-title":"BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression","volume":"16","author":"Jensen","year":"1998","journal-title":"Oncogene"},{"key":"10.1016\/j.cancergen.2015.12.007_bib0120","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1126\/science.1228463","article-title":"Cancer. Emerging anatomy of the BAP1 tumor suppressor system","volume":"337","author":"White","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.cancergen.2015.12.007_bib0125","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1126\/science.1221711","article-title":"Loss of the tumor suppressor BAP1 causes myeloid transformation","volume":"337","author":"Dey","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.cancergen.2015.12.007_bib0130","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1128\/MCB.01517-08","article-title":"Association of C-terminal ubiquitin hydrolase BRCA1-associated protein 1 with cell cycle regulator host cell factor 1","volume":"29","author":"Misaghi","year":"2009","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.cancergen.2015.12.007_bib0135","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ceb.2004.03.003","article-title":"Nonsense-mediated mRNA decay: terminating erroneous gene expression","volume":"16","author":"Baker","year":"2004","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.cancergen.2015.12.007_bib0140","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.cancergen.2013.05.018","article-title":"Further evidence for germline BAP1 mutations predisposing to melanoma and malignant mesothelioma","volume":"206","author":"Cheung","year":"2013","journal-title":"Cancer Genet"},{"key":"10.1016\/j.cancergen.2015.12.007_bib0145","article-title":"Comprehensive review of BAP1 tumor predisposition syndrome with report of two new cases","author":"Rai","year":"2015","journal-title":"Clin Genet"},{"key":"10.1016\/j.cancergen.2015.12.007_bib0150","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00428-006-0162-0","article-title":"How to define follicular thyroid carcinoma?","volume":"448","author":"Schmid","year":"2006","journal-title":"Virchows Arch"},{"key":"10.1016\/j.cancergen.2015.12.007_bib0155","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.mce.2009.10.013","article-title":"The role of the PAX8\/PPARgamma fusion oncogene in the pathogenesis of follicular thyroid cancer","volume":"321","author":"Eberhardt","year":"2010","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.cancergen.2015.12.007_bib0160","doi-asserted-by":"crossref","first-page":"E125","DOI":"10.1002\/hed.23936","article-title":"Collision tumours of the thyroid: an interesting case and review of the literature","volume":"37","author":"Ryan","year":"2014","journal-title":"Head Neck"},{"key":"10.1016\/j.cancergen.2015.12.007_bib0165","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/1477-7819-4-65","article-title":"Collision tumor of the thyroid: follicular variant of papillary carcinoma and squamous carcinoma","volume":"4","author":"Walvekar","year":"2006","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.cancergen.2015.12.007_bib0170","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1186\/1752-1947-5-590","article-title":"Medullary and papillary carcinoma of the thyroid gland occurring as a collision tumor with lymph node metastasis: a case report","volume":"5","author":"Sadat Alavi","year":"2011","journal-title":"J Med Case Rep"},{"key":"10.1016\/j.cancergen.2015.12.007_bib0175","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1136\/bjophthalmol-2013-303814","article-title":"BAP1 germline mutation in two first grade family members with uveal melanoma","volume":"98","author":"Maerker","year":"2014","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.cancergen.2015.12.007_bib0180","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1093\/annonc\/mdt135","article-title":"Well-differentiated papillary mesothelioma: clustering in a Portuguese family with a germline BAP1 mutation","volume":"24","author":"Ribeiro","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.cancergen.2015.12.007_bib0185","doi-asserted-by":"crossref","DOI":"10.1126\/science.1260419","article-title":"Proteomics. Tissue-based map of the human proteome","volume":"347","author":"Uhlen","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.cancergen.2015.12.007_bib0190","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/35066048","article-title":"Phenotype-genotype relationships in monogenic disease: lessons from the thalassaemias","volume":"2","author":"Weatherall","year":"2001","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.cancergen.2015.12.007_bib0195","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/35056009","article-title":"Modifier genes in mice and humans","volume":"2","author":"Nadeau","year":"2001","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.cancergen.2015.12.007_bib0200","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/jhg.2013.114","article-title":"The promise of whole-exome sequencing in medical genetics","volume":"59","author":"Rabbani","year":"2014","journal-title":"J Hum Genet"},{"key":"10.1016\/j.cancergen.2015.12.007_bib0205","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1001\/jama.2014.14601","article-title":"Molecular findings among patients referred for clinical whole-exome sequencing","volume":"312","author":"Yang","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.cancergen.2015.12.007_bib0210","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1136\/jmedgenet-2012-100819","article-title":"Clinical application of exome sequencing in undiagnosed genetic conditions","volume":"49","author":"Need","year":"2012","journal-title":"J Med Genet"}],"container-title":["Cancer Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210776215002550?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210776215002550?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,16]],"date-time":"2018-09-16T13:58:49Z","timestamp":1537106329000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210776215002550"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["S2210776215002550"],"URL":"https:\/\/doi.org\/10.1016\/j.cancergen.2015.12.007","relation":{},"ISSN":["2210-7762"],"issn-type":[{"value":"2210-7762","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel BAP1 mutation is associated with melanocytic neoplasms and thyroid cancer","name":"articletitle","label":"Article Title"},{"value":"Cancer Genetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cancergen.2015.12.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}